Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 5/20 | 0.54 |
| ▸ | RBP4 | P02753 | 7/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30128750 | 0.85 | ATM (0.50) | CHRM3RBP4ALDH1A1 | |
| SCHEMBL17294705 | 0.85 | ATM (0.50) | CHRM3RBP4ALDH1A1 | |
| SCHEMBL9792947 | 0.83 | CHRM3 (0.52) | CHRM3RBP4ALDH1A1 | |
| SCHEMBL6926259 | 0.78 | GRM2 (0.49) | CHRM3RBP4HTR6 | |
| SCHEMBL6425438 | 0.78 | CYP3A4 (0.43) | — | |
| Benzylic Acid SCHEMBL28790412 | 0.76 | CHRM3 (0.54) | CHRM3ALDH1A1CYP2C9 | |
| SCHEMBL4404703 | 0.75 | CYP2C9 (0.40) | CHRM3RBP4CYP2C9 | |
| SCHEMBL15935180 | 0.75 | RBP4 (0.44) | RBP4HTR6 | |
| SCHEMBL5160638 | 0.74 | IKBKB (0.41) | HTR6CYP2C9 | |
| SCHEMBL5712869 | 0.74 | CHRM2 (0.53) | CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110082203-A1 | PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY | BANYAN BIOMARKERS, INC. | 2011-04-07 | — | — | US | claimed |
| EP-2245466-A2 | PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY | Banyan Biomarkers, Inc. (US) | 2010-11-03 | — | — | EP | claimed |
| WO-2009100131-A2 | PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY | BANYAN BIOMARKERS, INC. (US) | 2009-08-13 | — | — | WO | claimed |
| WO-2024107948-A1 | BIOMARKER PANEL FOR BRAIN SPECIFIC ABNORMAL NEUROLOGICAL CONDITIONS USING BIOFLUID SAMPLES | GRYPHON BIO, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| US-10041959-B2 | Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury | BANYAN BIOMARKERS, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| EP-3355059-A2 | BIOMARKER ASSAY OF NEUROLOGICAL CONDITION | Banyan Biomarkers, Inc. (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-2478360-B1 | AUTOANTIBODY MARKERS FOR DIAGNOSIS OF TRAUMATIC BRAIN INJURY | BANYAN BIOMARKERS INC (US) | 2018-06-27 | — | — | EP | disclosed |
| US-20170315136-A9 | BIOMARKER ASSAY OF NEUROLOGICAL CONDITION | BANYAN BIOMARKERS, INC. (US) | 2017-11-02 | — | — | US | disclosed |
| US-20170242041-A1 | MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY | BANYAN BIOMARKERS, INC. (US) | 2017-08-24 | — | — | US | disclosed |
| EP-3115785-A2 | PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY | Banyan Biomarkers, Inc. (US) | 2017-01-11 | — | — | EP | disclosed |
| US-20150268252-A1 | BIOMARKER ASSAY OF NEUROLOGICAL CONDITION | BANYAN BIOMARKERS, INC. | 2015-09-24 | — | — | US | disclosed |
| US-20110097392-A1 | ANTIBODY BOUND SYNTHETIC VESICLE CONTAINING MOLECULES FOR DELIVER TO CENTRAL AND PERIPHERAL NERVOUS SYSTEM CELLS | BANYAN BIOMARKERS, INC | 2011-04-28 | — | — | US | disclosed |
| US-20110082203-A1 | PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY | BANYAN BIOMARKERS, INC. | 2011-04-07 | — | — | US | disclosed |
| WO-2011032155-A2 | MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY | BANYAN BIOMARKERS, INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011011334-A2 | SYNERGISTIC BIOMARKER ASSAY OF NEUROLGICAL CONDITION USING S-100β | BANYAN BIOMARKERS, INC. (US) | 2011-01-27 | — | — | WO | disclosed |
| EP-2274011-A2 | AN ANTIBODY BOUND SYNTHETIC VESICLE CONTAINING ACTIVE AGENT MOLECULES | Banyan Biomarkers, Inc. (US) | 2011-01-19 | — | — | EP | disclosed |
| WO-2010148391-A2 | BIOMARKER ASSAY OF NEUROLOGICAL CONDITION | BANYAN BIOMARKERS, INC. (US) | 2010-12-23 | — | — | WO | disclosed |
| EP-2245466-A2 | PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY | Banyan Biomarkers, Inc. (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009129476-A2 | AN ANTIBODY BOUND SYNTHETIC VESICLE CONTAINING ACTIVE AGENT MOLECULES | BANYAN BIOMARKERS, INC. (US) | 2009-10-22 | — | — | WO | disclosed |
| WO-2009100131-A2 | PROCESS TO DIAGNOSE OR TREAT BRAIN INJURY | BANYAN BIOMARKERS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |